See more : Guild Holdings Company (GHLD) Income Statement Analysis – Financial Results
Complete financial analysis of BIOTON S.A. (BIO.WA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of BIOTON S.A., a leading company in the Biotechnology industry within the Healthcare sector.
- NS Shopping Co., Ltd (138250.KS) Income Statement Analysis – Financial Results
- Guardant Health, Inc. (GH) Income Statement Analysis – Financial Results
- Solvay SA (SVYSF) Income Statement Analysis – Financial Results
- Asante Incorporated (ASNXF) Income Statement Analysis – Financial Results
- AssetMark Financial Holdings, Inc. (AMK) Income Statement Analysis – Financial Results
BIOTON S.A. (BIO.WA)
About BIOTON S.A.
BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceuticals, pharmaceutical preparations, pharmaceutical substances, medications, and other pharmaceutical products in Poland, China, Thailand, Vietnam, Libya, Argentina, Ukraine, Malta, Yemen, and the Russian Federation. The company offers recombinant human and classic insulin; oral anti-diabetic medication products; dietary supplements; strips for measuring sugar in blood, as well as OTC preparation for diabetics; diabetics drugs insulin vials and cartridges, including Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. It engages in advertising, advisory, and company management activities. The company was founded in 1989 and is based in Ozarów Mazowiecki, Poland.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 181.64M | 233.16M | 163.03M | 221.79M | 202.03M | 241.17M | 361.65M | 277.61M | 404.41M | 377.30M | 340.36M | 406.30M | 288.98M | 378.60M | 286.23M | 293.52M | 270.94M | 215.48M | 151.59M |
| Cost of Revenue | 108.78M | 137.41M | 85.25M | 117.09M | 99.87M | 125.04M | 175.38M | 139.59M | 237.32M | 219.01M | 194.55M | 192.84M | 186.40M | 166.06M | 174.92M | 164.37M | 122.93M | 81.64M | 70.40M |
| Gross Profit | 72.85M | 95.75M | 77.79M | 104.70M | 102.16M | 116.12M | 186.27M | 138.02M | 167.08M | 158.30M | 145.81M | 213.47M | 102.59M | 212.53M | 111.31M | 129.15M | 148.01M | 133.84M | 81.19M |
| Gross Profit Ratio | 40.11% | 41.07% | 47.71% | 47.21% | 50.57% | 48.15% | 51.51% | 49.72% | 41.32% | 41.96% | 42.84% | 52.54% | 35.50% | 56.14% | 38.89% | 44.00% | 54.63% | 62.11% | 53.56% |
| Research & Development | 5.51M | 5.34M | 4.67M | 4.00M | 6.84M | 32.98M | 8.85M | 7.59M | 3.58M | 3.80M | 9.81M | 6.18M | 8.36M | 14.17M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 30.47M | 30.27M | 27.90M | 38.75M | 38.64M | 50.83M | 54.00M | 54.04M | 64.66M | 61.76M | 60.77M | 78.06M | 95.11M | 100.46M | 123.83M | 72.70M | 59.91M | 40.94M | 22.52M |
| Selling & Marketing | 40.99M | 35.07M | 31.79M | 34.99M | 69.83M | 82.93M | 103.35M | 92.38M | 78.69M | 74.81M | 69.74M | 66.74M | 55.37M | 51.69M | 50.09M | 55.16M | 50.29M | 44.53M | 32.03M |
| SG&A | 71.46M | 65.34M | 59.69M | 73.74M | 108.47M | 133.77M | 157.36M | 146.42M | 143.35M | 136.58M | 130.51M | 144.80M | 150.48M | 152.15M | 173.92M | 127.86M | 110.20M | 85.47M | 54.55M |
| Other Expenses | -19.40M | -933.00K | 810.00K | -26.18M | 2.80M | -501.00K | 760.00K | 32.00K | 372.00K | 1.93M | 2.22M | 1.54M | -5.20M | -31.12M | -15.95M | 72.78M | -62.42M | -26.49M | -15.07M |
| Operating Expenses | 57.56M | 69.74M | 65.17M | 51.55M | 118.10M | 166.25M | 167.18M | 157.14M | 147.37M | 140.13M | 140.05M | 150.19M | 153.65M | 135.20M | 665.84M | 200.63M | 47.78M | 58.98M | 39.47M |
| Cost & Expenses | 166.34M | 207.15M | 150.42M | 168.64M | 217.97M | 291.29M | 342.56M | 296.73M | 384.70M | 359.13M | 334.60M | 343.03M | 340.04M | 301.26M | 840.77M | 365.00M | 170.71M | 140.62M | 109.87M |
| Interest Income | 0.00 | 7.86M | 4.54M | 3.00K | 1.67M | 5.34M | 212.00K | 139.00K | 2.30M | 1.40M | 2.39M | 787.00K | 27.41M | 19.71M | 51.19M | 22.62M | 8.06M | 46.94M | 4.30M |
| Interest Expense | 8.43M | 7.86M | 4.54M | 5.07M | 6.54M | 7.80M | 11.34M | 9.63M | 12.71M | 18.69M | 15.70M | 10.05M | 27.15M | 11.05M | 61.78M | 190.74M | 92.17M | 13.62M | 2.69M |
| Depreciation & Amortization | 28.24M | 34.40M | 31.64M | 29.23M | 29.92M | 29.49M | 32.12M | 31.29M | 37.28M | 33.79M | 29.98M | 36.29M | 37.09M | 38.64M | 31.10M | 23.73M | 20.72M | 13.68M | 9.28M |
| EBITDA | 50.46M | 58.56M | 45.09M | 76.26M | -124.52M | 52.69M | 22.17M | 21.42M | -495.70M | 67.06M | 38.26M | 94.38M | -12.22M | 125.97M | -507.91M | -53.53M | 47.92M | 124.35M | 51.73M |
| EBITDA Ratio | 27.78% | 22.29% | 26.24% | 36.90% | -19.18% | -5.54% | 11.27% | 8.17% | 16.32% | 17.77% | 11.24% | 20.38% | 4.65% | 35.84% | -170.56% | -18.24% | 47.20% | 62.27% | 34.13% |
| Operating Income | 15.30M | 21.26M | 11.15M | 48.58M | -15.94M | -52.41M | 18.03M | -13.89M | -502.86M | 22.11M | 10.88M | 66.95M | -51.06M | 77.33M | -567.84M | -71.49M | 100.23M | 74.86M | 41.72M |
| Operating Income Ratio | 8.42% | 9.12% | 6.84% | 21.90% | -7.89% | -21.73% | 4.99% | -5.00% | -124.34% | 5.86% | 3.20% | 16.48% | -17.67% | 20.43% | -198.39% | -24.36% | 36.99% | 34.74% | 27.52% |
| Total Other Income/Expenses | -8.06M | -16.31M | -6.01M | -6.97M | 1.44M | 67.58M | -23.87M | -6.90M | -33.15M | 1.33M | -7.11M | -17.97M | 256.00K | 8.66M | -35.70M | -168.12M | -91.97M | 32.03M | -1.96M |
| Income Before Tax | 7.23M | 4.95M | 8.33M | 41.61M | -162.10M | 15.17M | -5.84M | -20.80M | -547.05M | 23.43M | 2.30M | 48.04M | -50.80M | 85.99M | -594.37M | -268.00M | 14.99M | 106.88M | 39.76M |
| Income Before Tax Ratio | 3.98% | 2.12% | 5.11% | 18.76% | -80.24% | 6.29% | -1.62% | -7.49% | -135.27% | 6.21% | 0.68% | 11.82% | -17.58% | 22.71% | -207.66% | -91.31% | 5.53% | 49.60% | 26.23% |
| Income Tax Expense | 4.96M | 3.53M | 5.45M | 7.69M | -35.41M | -10.92M | 8.62M | -4.81M | -26.42M | 10.43M | 8.67M | 24.22M | -6.14M | 6.05M | -5.51M | -44.97M | -11.59M | 14.19M | 5.13M |
| Net Income | 2.28M | 1.42M | 2.88M | 33.92M | -126.69M | 26.27M | -7.27M | -28.57M | -522.86M | 3.68M | -6.44M | 37.84M | -83.94M | 110.73M | -599.88M | -223.03M | 26.57M | 92.70M | 34.63M |
| Net Income Ratio | 1.25% | 0.61% | 1.77% | 15.29% | -62.71% | 10.89% | -2.01% | -10.29% | -129.29% | 0.97% | -1.89% | 9.31% | -29.05% | 29.25% | -209.58% | -75.99% | 9.81% | 43.02% | 22.84% |
| EPS | 0.03 | 0.02 | 0.03 | 0.40 | -1.48 | 0.31 | -0.08 | -0.33 | -6.09 | 0.04 | -0.08 | 0.53 | -1.49 | 2.20 | -14.02 | -7.33 | 1.04 | 3.75 | 1.54 |
| EPS Diluted | 0.03 | 0.02 | 0.03 | 0.40 | -1.48 | 0.31 | -0.08 | -0.33 | -6.09 | 0.04 | -0.08 | 0.53 | -1.49 | 2.20 | -13.99 | -7.33 | 1.04 | 3.75 | 1.54 |
| Weighted Avg Shares Out | 85.86M | 85.86M | 85.86M | 85.86M | 85.86M | 85.86M | 85.86M | 85.86M | 85.83M | 85.86M | 84.53M | 71.47M | 56.20M | 53.17M | 42.79M | 30.43M | 26.98M | 24.72M | 12.52M |
| Weighted Avg Shares Out (Dil) | 85.86M | 85.86M | 85.86M | 85.86M | 85.86M | 85.86M | 85.86M | 85.86M | 85.86M | 85.86M | 84.53M | 71.47M | 56.20M | 53.17M | 42.89M | 30.43M | 26.98M | 24.72M | 12.52M |
Source: https://incomestatements.info
Category: Stock Reports